Help Center

[CMS 127v6] Pneumococcal (Pneumonia) Vaccine

Last Updated: Jul 25, 2018 01:31PM PDT

Contents
1. Measure Details
2. Measure Parameters
3. Meeting the Measure in Elation
4. Measure Information


1. Measure Details:
Report on the percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine.
 

2. Measure Parameters:

Numerator: Patients who have ever received a pneumococcal vaccine.

Denominator: Patients
65+ years of age who had an encounter during the measurement period (2018).

Exclusions/Exceptions: Patients in hospice care during the measurement year. 
 

3. Elation Workflows

Recording from a visit note:

1/ When a patient is due for a pneumococcal vaccine, an alert will show up at the top of the patient's visit note. Selecting Address on any of these will give a set of options to address that Clinical Quality Measure:


 

Addressing measures outside of a visit note:

1/ For a patient in the denominator, scroll to the bottom of their clinical profile and click on "+ Add Vaccination, detailed".
  • TIP= Do not select the "brand unknown" version of the vaccination because that will not be counted towards MIPS per CMS standards.
‚Äč
2/ Fill in the necessary fields and Save.
 
 

4. Measure Information

Pneumonia is a common cause of illness and death in the elderly and persons with certain underlying conditions such as heart failure, diabetes, cystic fibrosis, asthma, sickle cell anemia, or chronic obstructive pulmonary disease. In 1998, an estimated 3,400 adults aged > 65 years died as a result of invasive pneumococcal disease (IPD).
 
Among the 91.5 million US adults aged > 50 years, 29,500 cases of IPD, 502,600 cases of nonbacteremic pneumococcal pneumonia and 25,400 pneumococcal-related deaths are estimated to occur yearly; annual direct and indirect costs are estimated to total $3.7 billion and $1.8 billion, respectively. Pneumococcal disease remains a substantial burden among older US adults, despite increased coverage with 23-valent pneumococcal polysaccharide vaccine, (PPV23) and indirect benefits afforded by PCV7 vaccination of young children.
support@elationpassport.com
http://assets3.desk.com/
false
desk
Loading
seconds ago
a minute ago
minutes ago
an hour ago
hours ago
a day ago
days ago
about
false
Invalid characters found
/customer/en/portal/articles/autocomplete